Financial Capital Strategy
Aim to Achieve VISION 2030 stage2 by Implementing Investment and Financial Strategies That Focus on Capital Cost and Stock Price
FY2025 Performance Review
In FY2025, consolidated net sales were ¥130.9 billion, down 4.5% year on year; operating profit was ¥4.8 billion, down ¥3.0 billion; ordinary profit was ¥4.9 billion, down ¥3.2 billion; and net profit was ¥0.5 billion, down ¥5.7 billion, reflecting the recording of ¥3.3 billion in extraordinary losses related to structural reforms in the apparel business. The performance was grim, with both sales and profits declining.
By segment, the functional solutions business secured a slight year-on-year increase in operating profit of ¥7.2 billion. Although profit in the engineering plastics field declined due to the prolonged inventory adjustment phase in the semiconductor market, this was offset by higher profit from expanded sales in the domestic market in the plastic films field and the positive impact of the wind-down of the electronic components business in the previous fiscal year.
Moreover, the decrease in operating profit in the medical business year on year was limited to ¥1.4 billion, and due to sluggish sales in China and higher fixed costs associated with capital expenditures and other investments for business expansion.
The apparel business, currently undergoing structural reforms, posted an operating loss of ¥1.3 billion, reflecting the recording of ¥1.9 billion in inventory valuation losses.
Operating profit in the lifestyle creations business performed solidly with a year-on-year increase of ¥1.2 billion, supported by increased visitor traffic at shopping centers and a recovery in sales at existing sports clubs following structural reforms.
FY2026 Forecasts
Amid an uncertain operating environment in FY2026, including the impact of the situation in the Middle East, Gunze has set a target of ¥132.0 billion in net sales, or a 0.8% year-on-year increase. Although sales in the apparel business are expected to decline under the strategy to focus on specific areas, the Company anticipates expanded sales in the functional solutions and medical businesses. Operating profit is forecast at ¥8.8 billion, up ¥3.9 billion year on year, and net profit at ¥5.2 billion, up ¥4.6 billion, reflecting, among other factors, the absence of restructuring-related losses in the apparel business recorded in the previous fiscal year.
In the functional solutions business, net sales are forecast to increase 3.7% year on year, reflecting improved profitability in overseas plastic film operations and a recovery in semiconductor-related products in the engineering plastics field. Operating profit is expected to increase ¥1.0 billion year on year.
In the medical business, net sales are forecast to increase 9.1% year on year and operating profit to increase ¥0.3 billion, reflecting expanded sales of adhesion barriers and other products and an anticipated recovery in the Chinese market in the second half.
In the apparel business, net sales are forecast to decrease 3.4% year on year, and we are aiming for an increase in operating profit of ¥2.6 billion, based on the steady progress of structural reforms.
In the lifestyle creations business, net sales are forecast to achieve an increase of 3.8% year on year and operating profit an increase of slightly less than ¥0.1 billion, mainly due to improved profitability in the sports club field.
GVA / ROIC
Gunze Value Added (GVA; net operating profit after tax + dividend income – invested capital × WACC) in FY2025 was negative ¥4.0 billion, a deterioration of ¥3.1 billion year on year and ¥2.3 billion below the target. ROIC in FY2025 was 2.7%, down 1.6 percentage points year on year.
By segment, ROIC in the functional solutions business remained in the 10% range, despite a ¥1.4 billion increase in invested capital due to investments including plant expansion in the engineering plastics field.
ROIC in the medical business declined to 8.6%. Although the increase in invested capital was contained, the impact of the aforementioned decline in operating profit was significant.
ROIC in the apparel business temporarily turned negative due to the aforementioned inventory valuation losses, but is forecast to recover to the 2% range in FY2026. ROIC in the lifestyle creations business rose to 5.2%, supported by higher operating profit in the real estate-related and sports club fields.
Changes in Operating Profit, ROIC, and Total Assets
Recognition of Capital Cost
We recognize that enhancing corporate value requires accurately assessing the Company’s cost of capital and generating returns on capital that exceed it.
Under the previous Medium-term Management Plan (V30-1), based on internal estimates, the Company set its cost of equity capital at 6.32% and WACC at 5.15%. However, through continued dialogue with investors, we recognized that these levels were lower than those perceived by investors. Therefore, in estimating the cost of equity capital for VISION 2030 stage2 (V30-2), we made adjustments to incorporate the risk of future interest rate increases and add a risk premium for low stock liquidity, while also taking into account the levels perceived by investors. As a result, we set the cost of equity capital for V30-2 at 7.2%–7.8%.
Capital Policy and Cash Allocation
The ROE initially projected under V30-2 was expected to fall below the cost of equity capital under the existing capital structure, while ROIC was also expected to fall below WACC. We recognize that the most desirable course is to allocate cash to growth investments and rapidly generate a substantial increase in profit. However, given the characteristics of each of the businesses and the conditions at the time, we concluded that achieving such a significant increase in profit over a short period would not be realistic.
Accordingly, we determined that the capital structure needed to be reorganized to suit the Gunze Group’s level of earnings and decided to implement shareholder returns with a total return ratio exceeding 100%. Based on the D/E ratio at the end of FY2025, WACC is estimated at approximately 7%, but is expected to decline to approximately 6.0%–6.5% by the end of FY2027. In reorganizing the capital structure, we will proceed with the financial discipline of maintaining shareholders’ equity of ¥100 billion or more and an equity ratio of approximately 60%, while seeking to maintain our current external credit rating of A from Japan Credit Rating Agency, Ltd. (JCR).
Based on the V30-2 cash allocation plan incorporating this capital policy, in FY2025, of the approximately ¥17.2 billion generated through operating cash flow, we allocated approximately ¥6.3 billion to shareholder returns under a total return ratio of 100%, comprising dividends equivalent to a DOE of 4% and share buybacks, and approximately ¥5.0 billion to shareholder returns aimed at realigning the capital structure. In addition to the remaining operating cash flow, we used approximately ¥5.0 billion in long-term funds raised externally for capital expenditures, including expanding production capacity and constructing new plants in the medical business and engineering plastics field. Cash allocation progressed broadly in line with the V30-2 plan.
Although the FY2030 ROE target is 10% or more, government bond yields, which are generally used as the risk-free rate in calculating the cost of equity capital, have risen faster than anticipated. To generate further profit, we will therefore consider increasing the amount of cash allocated to growth investments.
Cash Allocation in V30-2 to Establish an Optimal Capital Structure
Dividend per Share, Dividend Payout Ratio / Treasury Stock
* The figures, including those for prior fiscal years, are presented on a post-stock-split basis. (The Company conducted a two-for-one stock split of its common stock on April 1, 2025.)
FY2025 Initiatives to Improve PER
In V30-2, alongside initiatives to improve return on capital, we are pursuing a policy to improve PER centered on increasing stock liquidity. This was prompted by feedback from several institutional investors that the Company’s shares were difficult to trade due to low liquidity. We therefore positioned improving stock liquidity as one of the key priorities under V30-2 and decided to first stimulate trading by individual investors.
Because Gunze’s existing shareholders had generally held their shares for extremely long periods and tended to be older, we implemented a stock split and revised the shareholder benefits program and shareholder return policy to attract new shareholders.
Since May 2025, the Company has attracted attention as a high-dividend stock, leading to a rise in the stock price and improved stock liquidity. However, excessive reliance on dividends and shareholder benefits could increase stock price volatility and raise beta, a component used in the theoretical calculation of the cost of equity capital. In addition, because Gunze handles consumer products such as innerwear, we believe it is important to cultivate loyal shareholders who are fans of both the Company and its products and will hold their shares over the long term.
Accordingly, in November 2025 and February 2026, we held online briefings for individual investors for the first time. The briefings attracted more than 4,000 viewers in total, and many of the individual investors who attended became Gunze’s shareholders.
As a result of these initiatives, stock liquidity more than doubled from its previous level, the number of individual shareholders increased by more than 20,000 from the end of the previous fiscal year, and their shareholding ratio exceeded 50%. In a survey conducted from November 2025 to January 2026 among shareholders eligible for the shareholder benefits program, 14,000 of the 18,000 respondents (78%) said that their intended approach to holding Gunze’s shares was “long-term holding (five years or more).”
While we achieved a certain degree of progress in improving stock liquidity, a new issue emerged: a decline in the shareholding ratio of overseas investors. We believe this decline reflects the fact that we have not sufficiently communicated our future growth potential. We recognize that an imbalanced shareholder composition could increase stock price volatility. In FY2026, we therefore plan to focus on creating opportunities for dialogue with overseas institutional investors.
Trends in Share Price and Trading Volume
Composition of Shareholders (Shareholding Ratios Excluding Treasury Stock)
Toward Further Enhancement of Corporate Value
In FY2025, the Company’s stock price rose and its PBR remained above 1. However, we believe this was driven more by the high dividend, including additional shareholder returns, than by operating performance or expectations for future growth. In particular, the medical business, which we position as a growth driver, continued to face challenges. We will therefore work to restore it to a growth trajectory at an early stage by expanding sales outside China and shifting toward a business portfolio centered on proprietary products. Our cash allocation policy remains unchanged: we will continue to prioritize investment in the medical and functional solutions businesses.
We recognize that a PBR of 1 is merely the minimum level expected of a listed company, and that surviving in the TSE Prime Market will require us to further enhance corporate value from this point forward. To enhance corporate value, we also believe it is necessary to raise employees’ awareness of stock price and capital cost.
To this end, we introduced FP&A (Financial Planning & Analysis) and finance-focused training (GVA/ROIC Ambassador Training) for younger finance and accounting personnel. For finance training, we also use external management schools and expect participants to grow through the stimulation and learning gained from interaction outside the Company. In addition, when soliciting new enrollment and increased contributions to the Gunze Group Employee Stock Ownership Plan as part of a campaign commemorating our 130th anniversary, we produced and distributed videos and internal newsletters containing information on stock price and stock investment to strengthen employees’ sense of participation in management. Approximately 1,000 employees applied for new enrollment or increased contributions. As a result, the participation rate in the employee stock ownership plan across the Gunze Group rose 4 percentage points from before the campaign to 45%.
The effects of GVA/ROIC tree management, introduced when V30-2 was formulated, are also beginning to emerge. Specifically, by incorporating progress reports against return-on-capital targets using the GVA/ROIC tree into regular meetings, discussions with a greater focus on GVA/ROIC have increased. A distinctive feature of our approach is that we use not only a percentage-based metric but also GVA as an amount-based metric, enabling discussions that take into account the magnitude of the impact on management.
As GVA/ROIC tree management has become more deeply embedded in the business divisions, the cash conversion cycle (CCC), which had continued to deteriorate since the COVID-19 pandemic, has been improving since FY2024. In FY2025, CCC was shortened by eight days year on year to 179 days, with improvements in the apparel business, where structural reforms are underway, making a particularly significant contribution.
To further enhance corporate value, we will continue working to improve the Company’s corporate fundamentals, including by changing employees’ mindsets.
V30-2 Financial Strategy Summary